Brian Santich in

Brian Santich

Doer · DISC type ds
Senior Director, Scientific Licensing at Johnson & Johnson
📍 New York City Metropolitan Area, United States

Brian Santich is a seasoned PhD scientist with over a decade of experience in oncology therapeutics, including radiopharmaceuticals and immunotherapies. In his current role in Scientific Licensing at Johnson & Johnson, he leverages his deep expertise in advancing drug programs from discovery to early clinical development, holding 11 patents.

Outside of his primary role, Brian is dedicated to continuous learning and professional growth. He has recently completed advanced certifications in Cell Therapy Manufacturing from MITx and AI for Organizational Leaders, reflecting a strong commitment to staying at the forefront of biotechnological and strategic innovation.

He developed a novel drug delivery platform (SADA) that was licensed for clinical development.

Read the full overview →
Experience
11 Years
Current Role
Senior Director, Scientific Licensing
Job Level
Senior
Location
New York City Metropolitan Area, United States
Personality Overview

How Brian shows up

Risk-Accepting
Results Focused
Strategic Planner

They are very professional in their approach and can weigh multiple perspectives together. They exhibit a rare combination of being result-oriented but patient at the same time. Reading between the lines and seeing beyond your words comes naturally to them.

Priorities

Topics Brian cares about

Oncology Therapeutics
His entire career, including his PhD and roles at Y-mAbs and Memorial Sloan Kettering, has been dedicated to advancing cancer therapies like immunotherapies and radiopharmaceuticals.
Drug Development
He has extensive experience leading programs from discovery and target validation through preclinical development and has contributed to multiple successful IND filings.
+6 more topics Login to view topics
Career

Work history

9-2025
Senior Director, Scientific Licensing
Johnson & Johnson
1-2025 - 8-2025
Vice President Research And Development
Y-mAbs Therapeutics, Inc.
1-2023 - 12-2024
Senior Director
Y-mAbs Therapeutics, Inc.
12-2020 - 12-2022
Scientific Director
Y-mAbs Therapeutics, Inc.
6-2019 - 6-2020
Guest Editor
Frontiers
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
Doctor of Philosophy (Ph.D.)
Gerstner Sloan Kettering Graduate School of Biomedical Sciences at Memorial Sloan Kettering Cancer Center
BA
University of California, Berkeley
Social presence
in
Behavioral profile

DISC profile (public)

d

Dominance (D)

Dominance (D) reflects how goal and task oriented a person is, and their ability to accomplish results irrespective of how demanding the circumstances might be. Those scoring high tend to be motivated by winning, competition, and success.

Other Johnson & Johnson Employees

Explore more public profiles from related professionals.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Brian. Free, 10 seconds.